RLI.NYSERli CORP

Form 4: RLI Corp CEO Craig Kliethermes Reports Stock Option Grant and Share Ownership

Sentiment:

SEC Filing


RLI Corp's CEO, Craig W. Kliethermes, reports the acquisition of stock options and changes in beneficial ownership of common stock.

Summary

  • Craig W. Kliethermes, CEO of RLI Corp, filed a Form 4 with the SEC on May 6, 2024.
  • The report details transactions related to RLI Corp's securities.
  • Kliethermes acquired 7,250 stock options on May 2, 2024, with an exercise price of $143.15, exercisable in 20% increments annually starting May 2, 2025, and expiring on May 2, 2032.
  • The report also indicates direct ownership of 60,654 shares of common stock.
  • Indirect ownership includes 7,643.54 shares held through the ESOP and 11,270.323 shares held through the Executive Deferred Compensation plan.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, so the sentiment is neutral. The stock option grant is a positive incentive for the CEO, but it's a standard practice.

Positives

  • The acquisition of stock options aligns the CEO's interests with those of the shareholders.
  • The vesting schedule of the stock options encourages long-term performance.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

  • Stock option grants are a common component of executive compensation packages in publicly traded companies like RLI Corp.
  • Vesting schedules, such as the 20% annual vesting described, are typical to incentivize long-term commitment.
  • Comparing the size of the grant and the exercise price to those of peer companies (e.g., Cincinnati Financial, W. R. Berkley) would provide further context.

Stakeholder Impact

  • Shareholders may view the stock option grant as a positive incentive for the CEO to drive long-term value.
  • Employees participating in the ESOP will see changes in their allocated shares reflected in the report.

Key Dates

DateDescription
05/02/2024Date of stock option grant and transaction.
05/02/2025First date that 20% of the stock options become exercisable.
05/02/2032Expiration date of the stock options.
05/06/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.